Some clinicians might neglect discussing benefits and harms of antimicrobials with their patients during advance care planning processes.

Many marginalized patients with disabilities reside in nursing homes and are more susceptible to antibiotic under- and overtreatment.

This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings.

Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens.

This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia.

Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains.

The WHO has a list of essential medicines. What about medicines that might not get to patients who need them on time?

Therapeutic security in inpatient psychiatric settings requires careful planning and implementation if it is to support both patients’ safety and dignity.

This commentary examines prevention policies that overly rely on liberty restrictions imposed by designs of inpatient psychiatric units’ structures and spaces.

Iatrogenic harms of so-called “zero-risk” approaches must be balanced against promoting patients’ goals of care.